U.S. Rep. Kathy Castor Introduces Bill to Increase Transparency in Rx Pricing, Lower Health Care Costs
Administration and pharmaceutical manufacturers; Require disclosure of agreements involving Most-Favored-Nation pricing commitments, tariff exemptions, domestic investment